Skip to main content
Fig. 4 | Clinical and Translational Allergy

Fig. 4

From: New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?

Fig. 4

Timeline for SABA position changes in asthma management according to the GINA guidelines 1995–2019 [36, 37]. ICS inhaled corticosteroids, LABA long acting beta2 agonist, RABA rapid acting beta2 agonist, SABA short acting beta2 agonist, SMART single inhaler maintenance and rescue therapy, MART maintenance and rescue therapy, BUD budesonide, BDP beclomethasone, FORM formoterol

Back to article page
\